Position in DXCM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,687,560
+$837,920 QoQ
Shares Held
69,600
+13.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#273
of 951 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $123,523,761 across 32 Medical Devices names. DXCM ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
72,655 | $22,874,700 | |
| 2 | GMED |
Globus Medical Inc
|
211,000 | $16,671,110 | |
| 3 | PEN |
Penumbra Inc
|
52,423 | $16,552,562 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
144,850 | $12,470,136 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
25,900 | $7,604,499 | |
| 6 | AVNS |
Avanos Medical, Inc.
|
251,000 | $6,244,880 | |
| 7 | STE |
STERIS plc
|
22,700 | $4,779,939 | |
| 8 | DXCM |
Dexcom Inc
This page
|
69,600 | $4,687,560 |
All Filings in DXCM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,687,560 | 69,600 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,849,640 | 61,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,331,774 | 50,200 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,364,500 | 50,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,390,687 | 50,300 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,414,500 | 50,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,888,500 | 50,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,352,000 | 50,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,669,000 | 50,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,935,000 | 50,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,204,500 | 50,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,665,000 | 50,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,425,500 | 50,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,809,000 | 50,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,662,000 | 50,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,027,000 | 50,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,726,500 | 50,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,395,000 | 12,500 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $6,711,875 | 12,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,835,750 | 12,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,337,500 | 12,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,492,375 | 12,500 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,621,500 | 12,500 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,441,436 | 13,200 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $6,283,700 | 15,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,731,750 | 25,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||